BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33005257)

  • 1. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
    Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
    Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
    Zhang S; Li L; Lin JY; Lin H
    World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
    Li L; Zhang S; Lin H; Lin JY
    Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma.
    Seo YS; Park JJ; Kim JH; Kim JY; Yeon JE; Kim JS; Byun KS; Bak YT
    Dig Dis Sci; 2007 Mar; 52(3):753-9. PubMed ID: 17237995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer.
    Alakus H; Grass G; Hennecken JK; Bollschweiler E; Schulte C; Drebber U; Baldus SE; Metzger R; Hölscher AH; Mönig SP
    Histol Histopathol; 2008 Aug; 23(8):917-23. PubMed ID: 18498066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
    Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
    BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Vav3 protein and its prognostic value in patients with gastric cancer.
    Tan B; Li Y; Shi X; Fan L; Zhao Q; Liu Y; Tan M; Liu Q; Jia N
    Pathol Res Pract; 2017 May; 213(5):435-440. PubMed ID: 28285969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer.
    Kushlinskii NE; Gershtein ES; Ivannikov AA; Davydov MM; Chang VL; Ognerubov NA; Stilidi IS
    Bull Exp Biol Med; 2019 Jan; 166(3):373-376. PubMed ID: 30627896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.
    Zlatarova ZI; Softova EB; Dokova KG; Messmer EM
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):425-31. PubMed ID: 21881840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tissue inhibitors of metalloproteinase 1 (TIMP-1) in gastric cancer tissue.
    Mroczko B; Lukaszewicz-Zajac M; Groblewska M; Czyzewska J; Gryko M; Guzińska-Ustymowicz K; Kemona A; Kedra B; Szmitkowski M
    Folia Histochem Cytobiol; 2009 Jan; 47(3):511-6. PubMed ID: 20164040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomartker for invasion and its impact on survival.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Yanoma S; Noguchi Y
    Cancer; 2001 May; 91(9):1739-44. PubMed ID: 11335899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
    Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
    Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment serum and plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer patients.
    Mroczko B; Groblewska M; Łukaszewicz-Zajac M; Bandurski R; Kedra B; Szmitkowski M
    Clin Chem Lab Med; 2009; 47(9):1133-9. PubMed ID: 19728856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their inhibitors in gastric cancer.
    Murray GI; Duncan ME; Arbuckle E; Melvin WT; Fothergill JE
    Gut; 1998 Dec; 43(6):791-7. PubMed ID: 9824606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Miyagi Y
    Gastric Cancer; 2006; 9(2):106-13. PubMed ID: 16767366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.